Search Results - Melo, EC Vasquez

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Costo De Eventos Coronarios Agudos En Población Con Factores De Riesgo Cardiovascular: Análisis Retrospectivo

    Costo De Eventos Coronarios Agudos En Población Con Factores De Riesgo Cardiovascular: Análisis Retrospectivo by Romero Prada, ME, Huerfano, LM, Vasquez Melo, EC

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    PND45 - Cost Minimization Of 10% Intravenous Immunoglobulin Against Other Intravenous Immunoglobulin For Treating Primary Inmunodeficiencies

    PND45 - Cost Minimization Of 10% Intravenous Immunoglobulin Against Other Intravenous Immunoglobulin For Treating Primary Inmunodeficiencies by Romero Prada, ME, Huerfano, LM, Vasquez Melo, EC, Roa Cardenas, NC

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Cost Minimization Of 10% Intravenous Immunoglobulin Against Other Intravenous Immunoglobulin For Treating Primary Inmunodeficiencies

    Cost Minimization Of 10% Intravenous Immunoglobulin Against Other Intravenous Immunoglobulin For Treating Primary Inmunodeficiencies by Romero Prada, ME, Huerfano, LM, Vasquez Melo, EC, Roa Cardenas, NC

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Cost-Effectiveness of Using Brentuximab Vedotin in Patients with Recurrent Hodgkin Lymphoma or Refractory to Transplant

    Cost-Effectiveness of Using Brentuximab Vedotin in Patients with Recurrent Hodgkin Lymphoma or Refractory to Transplant by Romero Prada, ME, Roa Cardenas, NC, Vasquez Melo, EC, Acero, G, Huerfano, LM, de Los Rios de Acevedo, M

    Published in Value in health
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    PCN140 - Cost-Effectiveness of Using Brentuximab Vedotin in Patients with Recurrent Hodgkin Lymphoma or Refractory to Transplant

    PCN140 - Cost-Effectiveness of Using Brentuximab Vedotin in Patients with Recurrent Hodgkin Lymphoma or Refractory to Transplant by Romero Prada, ME, Roa Cardenas, NC, Vasquez Melo, EC, Acero, G, Huerfano, LM, de Los Rios de Acevedo, M

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    PCV4 - Costo De Eventos Coronarios Agudos En Población Con Factores De Riesgo Cardiovascular: Análisis Retrospectivo

    PCV4 - Costo De Eventos Coronarios Agudos En Población Con Factores De Riesgo Cardiovascular: Análisis Retrospectivo by Romero Prada, ME, Huerfano, LM, Vasquez Melo, EC

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    ECONOMIC IMPACT ANALYSIS OF BRCA1 AND BRCA2 GENETIC TESTS IN WOMEN WITH ADVANCED STAGE OVARIAN CANCER IN THE COLOMBIAN CONTEXT

    ECONOMIC IMPACT ANALYSIS OF BRCA1 AND BRCA2 GENETIC TESTS IN WOMEN WITH ADVANCED STAGE OVARIAN CANCER IN THE COLOMBIAN CONTEXT by Prada, ME Romero, Cardenas, NC Roa, Melo, EC Vasquez, Acosta, JA

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    ECONOMIC IMPACT OF THE USE OF THE PHARMACOGENETIC TEST OBTAINED FROM A SALIVA SAMPLE IN COLOMBIAN PATIENTS WITH MAJOR DEPRESSION

    ECONOMIC IMPACT OF THE USE OF THE PHARMACOGENETIC TEST OBTAINED FROM A SALIVA SAMPLE IN COLOMBIAN PATIENTS WITH MAJOR DEPRESSION by Prada, ME Romero, Beltran, JP Albanes, Cardenas, NC Roa, Melo, EC Vasquez

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    COSTO DE EVENTOS CORONARIOS AGUDOS EN POBLACIÓN CON FACTORES DE RIESGO CARDIOVASCULAR: ANÁLISIS RETROSPECTIVO

    COSTO DE EVENTOS CORONARIOS AGUDOS EN POBLACIÓN CON FACTORES DE RIESGO CARDIOVASCULAR: ANÁLISIS RETROSPECTIVO by Prada, ME Romero, Huerfano, LM, Melo, EC Vasquez

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: